Singapore markets closed

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.260.00 (0.00%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,239,227
1,155,840
1,111,011
1,042,306
736,064
Cost of revenue
911,166
839,036
807,962
747,920
484,234
Gross profit
328,061
316,804
303,048
294,386
251,830
Operating expenses
Research development
58,469
55,645
53,867
41,459
36,587
Selling general and administrative
59,735
59,038
65,883
49,898
26,010
Total operating expenses
181,661
178,274
182,022
165,468
137,403
Operating income or loss
146,400
138,530
121,026
128,918
114,427
Interest expense
15,338
15,251
11,177
7,040
5,002
Income before tax
130,670
121,441
112,851
118,735
118,282
Income tax expense
13,675
12,327
18,419
18,586
17,835
Income from continuing operations
116,995
109,115
94,432
100,149
100,447
Net income
120,492
112,199
95,029
101,370
100,447
Net income available to common shareholders
120,492
112,199
95,029
101,370
100,447
Basic EPS
0.71
0.83
0.72
0.76
0.77
Diluted EPS
0.70
0.83
0.71
0.76
0.77
Basic average shares
133,344
135,180
131,984
133,382
130,450
Diluted average shares
135,203
135,180
133,843
133,382
130,450